+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Escherichia Coli Testing Market - Growth, Trends, and Forecasts (2020 - 2025)

  • ID: 4896102
  • Report
  • June 2020
  • Region: Global
  • 112 Pages
  • Mordor Intelligence


  • Bio-Rad Laboratories Inc
  • Caisson Laboratories, Inc
  • Corning Incorporated
  • GE Healthcare
  • Lonza Group Ltd
  • Merck & Co., Inc
The Escherichia coli testing market is expected to grow with a CAGR of 8.1%, during the forecast period. Escherichia coli are bacterium or germs that are commonly found in the environment, foods in the gut of humans and warm-blooded animals.

Most of the Escherichia coli strains are harmless but some strains such as Shiga toxin-producing E.coli, can cause severe foodborne disease and mostly transmitted through consumption of undercooked or raw ground meat products, raw milk, and contaminated raw vegetables and sprouts. Symptoms of the diseases caused by Shiga toxin-producing E.coli (STEC) include abdominal cramps, diarrhoea, bloody diarrhoea (haemorrhagic colitis), fever and vomiting.

In the case of water treatment plants, Escherichia coli is the test organism for finding out the effectiveness of the effluent disinfection treatment process. According to an article published in the Journal Emerging Infectious Diseases, Escherichia coli accounts for over 85% of all urinary tract infections. Increasing prevalence of diarrhoea and high government funding are the key factors that drive the growth of E. coli testing market.

Key Market Trends

Enzyme Substrate Segment is Expected to be Major Segment in the Escherichia coli Testing Market

Enzyme substrate tests use hydrolyzable fluorogenic substrates to simultaneously detect enzymes produced by total Escherichia coli (E. coli). Most Escherichia coli strains produce enzyme β-glucuronidase, which cleaves a fluorogenic substrate in the medium to release fluorogen and the release of fluorogen indicates that E. coli are present.

The demand for enzyme-substrate methods has increased in the past few years. Enzyme substrate methods are easy to perform and do not require any sophisticated laboratory equipment and skilled personnel. The enzyme-substrate method is also performed based on presence or absence (P/A) tests. P/A tests are qualitative tests that produce colored substrate indicating the presence of E.coli in the water sample and these P/A test is easy to perform wherein only a small or medium size incubator is required to store test bottles. Based on the same principle, the P/A tests have modified to provide a quantitative most probable number (MPN) count of E.coli in the water sample.

Therefore with the increasing government support and development of drug-resistant species of Escherichia coli (E. coli) are the major driving factor for the global Escherichia coli testing market.

North America is Expected to hold the Market Share is Expected to do Same in the Forecast Period

North America is expected to hold the largest share globally in the Escherichia coli (E. coli) market in the year 2017. According to the North Carolina Department of Health and Human Services, every year in the United States, infections caused by Escherichia coli (E. coli) approximately 265,000 illnesses and about 100 deaths.

Approximately 40 percent of these infections are caused by the strain Escherichia coli (E. coli) O157:H7, part of the shiga toxin-producing group of Escherichia coli (E. coli) bacteria (STEC) and other 60 percent of Escherichia coli (E. coli) cases are caused by non-0157:H7 shiga toxin-producing Escherichia coli (E. coli) (STEC). Moreover, increasing awareness regarding the hygienic, the introduction of advanced testing technologies in this region is fueling the growth of the overall regional market to a large extent.

Competitive Landscape

The Escherichia coli Testing Market is moderately competitive and consists of of several major players. In terms of market share, few of the major players are currently dominating the market. Some of the companies which are currently domianting the market are Thermo Fisher Scientific, Alere Inc, Becton, Dickinson and Company, BioMerieux Inc, NanoLogix, Inc, Meridian Bioscience, Bio-Rad Laboratories, CPI International, Inc, Pro-Lab Diagnostics, Inc, IDEXX Laboratories, Inc.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

This product will be delivered within 2 business days.
Note: Product cover images may vary from those shown


  • Bio-Rad Laboratories Inc
  • Caisson Laboratories, Inc
  • Corning Incorporated
  • GE Healthcare
  • Lonza Group Ltd
  • Merck & Co., Inc

1.1 Study Assumptions
1.2 Scope of the Study
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Diarrhoea
4.2.2 New Technological Advancements
4.3 Market Restraints
4.3.1 High Cost of E. coli Treatment
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1 By Test
5.1.1 Clinical Testing Polymerase Chain Reaction Enzyme Immunoassays
5.1.2 Environmental Testing Membrane Filtration Multiple Tube Fermentation Enzyme Substrate Method
5.2 Geography
5.2.1 North America United States Canada Mexico
5.2.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.2.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.2.4 Middle-East and Africa GCC South Africa Rest of Middle-East and Africa
5.2.5 South America Brazil Argentina Rest of South America
6.1 Company Profiles
6.1.1 Becton, Dickinson and Company
6.1.2 Bio-Rad Laboratories Inc
6.1.3 Caisson Laboratories, Inc
6.1.4 Cell Culture Technologies LLC
6.1.5 Corning Incorporated
6.1.6 Fujifilm Holdings Corporation
6.1.7 GE Healthcare
6.1.8 HiMedia Laboratories Pvt., Ltd
6.1.9 Lonza Group Ltd
6.1.10 Merck & Co., Inc
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Becton, Dickinson and Company
  • Bio-Rad Laboratories Inc
  • Caisson Laboratories, Inc
  • Cell Culture Technologies LLC
  • Corning Incorporated
  • Fujifilm Holdings Corporation
  • GE Healthcare
  • HiMedia Laboratories Pvt., Ltd
  • Lonza Group Ltd
  • Merck & Co., Inc
Note: Product cover images may vary from those shown